Abbington House urges caution on costly NAD+ infusions marketed to vulnerable patients

A Hertfordshire rehab clinic has warned that vulnerable people in recovery are being targeted with costly “miracle” treatments for addiction that lack robust scientific backing.

Abbington House, a residential treatment centre in Stevenage, says it has seen a growing number of enquiries from families confused about so-called NAD+ infusions — intravenous drips marketed by some clinics as a fast-track cure for addiction, depression and fatigue.

NAD+ (nicotinamide adenine dinucleotide) is a compound found naturally in the body, but while it is essential for energy production, there is little clinical evidence to suggest that IV infusions can treat alcohol or drug dependency. Despite this, some UK providers are advertising packages costing from several hundred pounds up to more than £2,000.

Michael Williams, Treatment Manager at Abbington House, said the practice risks exploiting people at their most vulnerable:

Abbington House, residential treatment centreplaceholder image
Abbington House, residential treatment centre

“Recovery is a journey that requires medical support, therapeutic structure, and time. Selling unproven drips at such high cost gives false hope, and in some cases may even prevent people from engaging with the treatments that we know are effective. Families deserve clarity, not marketing spin.”

Abbington House emphasises that addiction recovery is most successful when programmes are rooted in evidence-based practice — combining medical detox where appropriate with structured therapy, relapse prevention planning, and holistic support.

While IV wellness treatments have grown in popularity in recent years, critics say they are often marketed without sufficient oversight. The Medicines and Healthcare products Regulatory Agency (MHRA) has previously taken action against clinics for misleading advertising, warning that claims about unproven therapies can breach consumer protection rules.

Williams added that the issue is not about stifling innovation, but about protecting people who may be desperate for a solution: “When someone reaches the point of seeking treatment, it’s a life-changing decision. They need honesty and professionalism. As treatment providers, we have an ethical responsibility to ensure that every option we present is safe, regulated and backed by evidence.”

Michael Williams, Treatment Managerplaceholder image
Michael Williams, Treatment Manager

Abbington House is calling for clearer regulation around the marketing of experimental or alternative treatments in the addiction sector, and for families to research providers carefully before committing to any course of care.

Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice